2003 Annual Report (PDF) - Foundation for the National Institutes of ...

2003Annual Report

2003Annual ReportLETTER FROM THE CHAIRMAN AND EXECUTIVE DIRECTOR 1YEAR IN REVIEW 2INDEPENDENT AUDITOR’S REPORT 7BALANCE SHEETS - DECEMBER 31, 2003 AND 2002 8STATEMENT OF ACTIVITIES -YEAR ENDED DECEMBER 31, 2003 9STATEMENT OF ACTIVITIES -YEAR ENDED DECEMBER 31, 2002 10STATEMENTS OF CASH FLOWS -YEARS ENDED DECEMBER 31, 2003 AND 2002 11NOTES TO FINANCIAL STATEMENTS -DECEMBER 31, 2003 AND 2002 12INDEPENDENT AUDITOR’S REPORT ONSUPPLEMENTARY INFORMATION 19SCHEDULE OF FUNCTIONAL EXPENSES 20DONORS 22BOARD OF DIRECTORS 28STAFFINSIDEBACK COVERThe Foundation for the National Institutes of Health, Inc. was established by the United States Congress to supportthe mission of the National Institutes of Health (NIH): improving health through scientific discovery. TheFoundation identifies and develops opportunities for innovative public-private partnerships involving industry,academia, and the philanthropic community. A non-profit, 501(c)(3) corporation, the Foundation raises privatesectorfunds for a broad portfolio of unique programs that complement and enhance NIH priorities and activities.

July 2004Dear Friends:By any measure, 2003 will stand as an historic year in the relatively short life of the Foundation for the NationalInstitutes of Health. Our work with partners, donors, and the National Institutes of Health has broadened anddeepened dramatically.Partners and donors to the Foundation have been able to leverage their generosity and support across an extraordinaryarray of diverse programs supporting the mission of the world’s leading health science research organization—the NIH.The Foundation is their bridge to direct partnership with NIH scientists and programs.In some instances, the generosity and support of Foundation donors have been applied in situations in which the timelyinfusion of funds has helped boost NIH projects that were especially ripe with promise—ones that could accelerateavailability of more effective disease preventions or treatments. The completion of the sequencing of the Mouse Genomeand the new Alzheimer’s Disease Neuroimaging Initiative fit this pattern.In pursuing new directions, the Foundation has also sought to advance research which complements NIH researchprograms. This is exemplified by the Grand Challenges in Global Health initiative to address treatment of diseases in thedeveloping world. This innovative grant-making program is managed and administered by the Foundation for NIHand funded by a visionary $200 million grant in 2003 from the Bill & Melinda Gates Foundation. NIH Director EliasA. Zerhouni, M.D. has an ongoing, active involvement with the Foundation in this program through his leadershiprole as a member of the Executive Committee of the 21-member Scientific Board for the Grand Challenges initiative.Other members of the Scientific Board from NIH or who previously held top NIH leadership positions are: AnthonyS. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases; Richard Klausner, M.D.,executive director, global health, Bill & Melinda Gates Foundation and former director of the National CancerInstitute; and Gerald T. Keusch, M.D., assistant provost for global health, medical campus and associate dean for globalhealth, Boston University and former director of the Fogarty International Center at NIH. Harold Varmus, M.D.,president of Memorial Sloan-Kettering Cancer Center and former director of NIH, chairs the Scientific Board.Where appropriate, as with the Grand Challenges initiative, the Foundation for NIH supports programs with potentialfor dramatic scientific breakthrough where the odds of scientific success may be longer than what is typically acceptable ingovernment-funded scientific research. When a proposal has strong scientific merit and the discovery in prospect is feasibleand high-impact, such funding has a crucial role. These programs can also fill unmet needs by supporting research that,for various reasons, is currently not adequately supported by standard funding sources, while avoiding duplicating or onlyadding to existing funding streams.The Foundation received $11.8 million in private-sector contributions, grants and interest during 2003. The UnitedStates Congress appropriated $496,000 and NIH provided $429,000 of in-kind and donated services, to help fundFoundation operations. Revenues for the 12 months ending December 31, 2003 amounted to $12.7 million, and netassets increased by 40.4 percent to a total of $14.4 million at year-end. The Foundation expended $7.2 million forprogram services and $1.3 million for supporting services (management and general administration, and fundraising)during 2003. Thus, for every dollar spent, 85 cents supported programs and 15 cents funded administration andfundraising activities. The Foundation posted $198.9 million as deferred grant revenue of the $200 million provided bythe Bill & Melinda Gates Foundation to support the Grand Challenges initiative.The Foundation’s board of directors was strengthened by the additions of Mark D. Ein, Steven M. Paul, M.D., and EllenV. Sigal, Ph.D. Mr. Ein is the founder and chief executive officer of Venturehouse Group, LLC, a holding company thatcreates, invests in and builds technology and telecommunications companies. Dr. Paul is executive vice president forscience and technology at Eli Lilly and Company and president of Lilly Research Laboratories. Dr. Sigal is the founderand chairperson of Friends of Cancer Research, serves on the Board of Scientific Advisors for the National CancerInstitute, and, most recently, was named to the National Institute of Health Director’s Council of Public Representatives.Last year, we completely revamped the Foundation’s internet Web site, www. fnih.org, to bring its look, architectureand “functionality” more in line with the character of the Foundation. We hope that its ease-of-use and visual appealwill be viewed as a major improvement. A visit to the Web site periodically will bring you up-to-date on Foundationactivities, new programs and partnerships.Public-private partnerships are essential to accelerating scientific discovery for human health. The Foundation for NIHis a seedbed of innovation and adaptation in bold public-private initiatives for biomedical research. Here the passion,imagination, generosity and insight of our partners, donors and a dedicated, highly professional foundation staffconverge in a very special way. Last year witnessed the inauguration of partnerships of such scale and originality thatthey are unprecedented not only for our foundation, but, perhaps, for any foundation. That being said, 2004 will be ayear requiring a highly focused effort to deliver on the promise of these pioneering programs—even as important newones appear on the horizon.Thanks for your continuing support.Charles A. Sanders, M.D.ChairmanAmy L. McGuireExecutive Director

FOUND2003Annual ReportYEAR IN REVIEWGrand Challenges in Global HealthThe Grand Challenges in Global Health initiative was funded by the Bill & MelindaGates Foundation in 2003 and is managed and administered by the Foundation for theNational Institutes of Health.The initiative was first announced by Bill Gates at a meeting of the World EconomicForum in Davos, Switzerland, on January 26, 2003. A grant of $200 million wassubsequently made to the Foundation for NIH to fund the program. The intent of theinitiative is to engage creative minds from across the world and the breadth of scientificand technology communities, including those who have not traditionally engaged inglobal health research, to partner in developing solutions to critical scientific andtechnological problems that, if solved, could lead to important advances against diseasesof the developing world.The work of the Foundation for NIH on the Grand Challenges initiative is guided byan international scientific board (SB) chaired by Nobel laureate Harold Varmus, M.D.,president of Memorial Sloan-Kettering Cancer Center and former director of theNational Institutes of Health. The scientific board comprises 21 scientists and publichealth experts from 13 countries, including several of the developing world. Dr.Varmusis joined on the SB executive committee by Richard Klausner, M.D., executive directorof the global health program at the Bill & Melinda Gates Foundation and Elias A.Zerhouni, M.D., director of the National Institutes of Health.The initiative began with a Call for Ideas, issued in May 2003. The internationalcommunity was asked to submit ideas on what the greatest scientific and technologicalchallenges in global health are. From over 1,000 ideas submitted from 75 countries, thescientific board developed a first set of 14 Grand Challenges. These challenges werepublished widely on October 17, together with an announcement that the Foundationfor NIH sought grant proposals for research on these challenges. Approximately, 1,500letters of intent from 75 countries were received by the January 9, 2004 deadline—lessthan one year after the announcement of the contemplated initiative. The grantsprogram is open, inclusive, and flexible. All investigators worldwide were eligible toapply, so long as they were sponsored by an organization that can accept responsibilityfor the research. The Foundation hopes to award grants of up to $20 million each overfive years that address the published challenges beginning in early 2005.The Grand Challenges initiative is based on the recognition that poor health is one of thegreatest impediments to international development. Although the scientific community hasthe resources and brainpower to develop new, innovative, and more affordable solutions tohealth problems in developing countries, only a small fraction of existing biomedical researchefforts are directed toward health problems that disproportionately affect the 2 billionpoorest people on earth. To date, there has been no systematic effort to identify the mostcritical scientific challenges in global health and direct funds to solve them. By directingsubstantial and carefully targeted resources toward key health-related research questions2 FOUNDATION FOR THE National Institutes of Health, Inc.EXPANDING BOUNDARIES FOR HUMAN HEALTH

ATIONFOR THENational Institutes of Health, Inc.pertinent to developing countries, the Grand Challenges initiative is intended to attract talentedinvestigators to address these issues and significantly accelerate the development of affordable,practical solutions.Overcoming Barriers to Early Phase Clinical TrialsThis $5.8 million public-private partnership connects the National Cancer Institute (NCI)and five industry partners—Bristol-Myers Squibb, Aventis Pharmaceuticals, NovartisPharmaceuticals, Eli Lilly and Company, and GlaxoSmithKline—in a program to helpclinical and comprehensive cancer centers increase patient participation in early stage (PhaseI and II) clinical trials, specifically targeting older and minority patients. The Friends ofCancer Research played a pivotal role in bringing about this important initiative, and theAssociation of American Cancer Institutes also provided vital support.In July, Secretary of Health and Human Services Tommy Thompson announced the sixcancer centers chosen by an NCI selection committee to receive grant awards: MassachusettsGeneral Hospital, University of Colorado Health Sciences Center, Washington University,St. Louis, University of Pittsburgh Cancer Institute, University of California, Davis CancerCenter and Ohio State University Comprehensive Cancer Center.Ellen Sigal, one of the newest members of the Foundation Board and founder and chairpersonof Friends of Cancer Research, hosted the announcement press conference on Capitol Hill.Joining Secretary Thompson were Senators Wayne Allard, Ben Nighthorse Campbell, EdwardM. Kennedy, Rick Santorum, and Representative William Lacy Clay. NCI Director Andrewvon Eschenbach, M.D. and Foundation for NIH Executive Director Amy L. McGuire bothdiscussed the critical role of public-private partnerships in biomedical research.Innovation in Prevention Award DinnerOn Dec. 10, 2003 the Department of Health and Human Services (DHHS) and theFoundation for the National Institutes of Health co-sponsored a gala dinner in Washington,D.C. to honor eight organizations from across the country with the first Innovation inPrevention Awards. Award presenter DHHS Secretary Tommy Thompson was joined forthe occasion by then Food and Drug Administration Commissioner Mark B. McClellan,M.D., Ph.D., U.S. Surgeon General Richard Carmona, M.D., M.P.H., F.A.C.S.,Julie Gerberding, M.D., M.P.H., director, Centers for Disease Control and Prevention,Olympic Gold Medalist Kerri Strug, and other distinguished guests. The award recognizesorganizations for taking innovative measures in the fight to prevent chronic diseases such asdiabetes, cancer, heart disease, stroke and asthma by promoting healthy lifestyles thatinclude a better diet and exercise.Receiving the award were: The Church Health Center, Southeast Kentucky CommunityAccess Program, Waco-McLennan County Public Health District Worksite WellnessTraining Program, Johnson & Johnson, Union Pacific Railroad, The American CancerSocieties Healthy Kids Network, Seattle-King County Healthy Homes Project, andCampuses Organized & United for Good Health (COUGH).EXPANDING BOUNDARIES FOR HUMAN HEALTHFOUNDATION FOR THE National Institutes of Health, Inc. 3

FOUND2003Annual ReportThe gala event was made possible by: Abbott Laboratories; the American Association ofHealth Plans-Health Insurance Association of America; AstraZeneca LP; Bristol-MyersSquibb; The Coca-Cola Company; Eli Lilly and Company; GlaxoSmithKline; the GroceryManufacturers of America; H.J. Heinz Company Foundation; Kraft Foods; Mars,Incorporated; Nestlé USA; Novartis Pharmaceuticals Corporation; PEPSICO; Pfizer Inc;Rodale Inc.; and, The Susan G. Komen Breast Cancer Foundation. Steinway & Sons, ThePartnership for Prevention, and William L. Roper, M.D., M.P.H., dean of public health,University of North Carolina also facilitated the event.Best Pharmaceuticals for ChildrenThe Best Pharmaceuticals for Children Act, signed into law by President George W. Bush inJanuary 2002, calls for the Foundation for NIH to raise funds to enable testing of drugs thatare approved for adult use and used to treat children, but have not been tested for treatmentof children. The need is great. At least 75 percent of drugs regularly prescribed to children inthe United States have never been labeled for use in children.The Merck Company Foundation made the first pledge to support the Best Pharmaceuticalsfor Children Fund—$1 million over three years. By Dec. 31, 2003, year-end, pledges to theBest Pharmaceuticals Fund totaled $3.6 million. The Food and Drug Administration and theSecretary of Health and Human Services have referred four drugs to the Foundation for NIH.Moreover, additional drug referrals from the FDA are expected.Edmond J. Safra Family LodgeIn 2003, Mrs. Lily Safra and The Edmond J. Safra Philanthropic Foundation pledged $1.75million for the construction of the Edmond J. Safra Family Lodge and for the creation of aspecial garden on its grounds at the Bethesda, Md. campus of the NIH. This follows an initial$3 million contribution to the construction made in memory of her late husband—the mostsignificant contribution ever received by the Foundation from an individual donor. Scheduledto open early in 2005, the Safra Lodge will provide overnight and temporary residenceaccommodations on the NIH campus to family members of patients participating in clinicaltrials at the NIH Clinical Center.The Helix and the Genome: 50 Years from Model to MedicineIn April 2003, a year of successful Foundation for NIH fundraising and event planningled by Foundation board member Mrs. William McCormick Blair, Jr. culminated insymposia for scientists and the general public, museum exhibits, school and communityoutreach activities, and extensive news media coverage which marked the five decadesbetween the description of the DNA double helix and the completion in 2003 of thecomprehensive sequencing of the human genome. A gala dinner celebration organized bythe Foundation and held at the Library of Congress drew Nobel laureates and other worldfamousscientists, senior industry executives, government officials, distinguishedjournalists, and other notable participants in observance of the 50 years of scientificresearch and discovery in the field. Foundation Chairman Charles A. Sanders andMrs. Blair were dinner committee co-chairmen.4 FOUNDATION FOR THE National Institutes of Health, Inc.EXPANDING BOUNDARIES FOR HUMAN HEALTH

ATIONFOR THENational Institutes of Health, Inc.Sequencing the human genome, the genetic blueprint for all human life, stands as alandmark in the history of bioscience. Dr. Zerhouni has characterized the Human GenomeProject as a model of how NIH fulfills its mission through support of innovation andcollaboration—collaboration with other federal agencies, with academic researchersthroughout the world and at NIH, and with private industry.A portion of the funds remaining following the April activities was directed to support aNovember conference investigating potential gene-based therapies for Sickle Cell Disease.Clinical Research Training ProgramTo reverse the worrisome decline in the number of physicians conducting clinical research,Pfizer Pharmaceuticals Group partnered with the Foundation for NIH in 1998 to establishthe Clinical Research Training Program (CRTP) which awards fellowships at NIH to 15medical and dental students each year. During 2003, Pfizer committed to three more years ofsupport for CRTP, an initiative which correlates well with the NIH Roadmap focus onResearch Teams of the Future.Osteoarthritis InitiativeThis $60 million public-private research partnership involves the National Institute onAging, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and otheragencies, together with three current industry partners: Pfizer; Merck; and Novartis. Begun in1999, the initiative aims to develop standardized means to gauge the progress of osteoarthritis.These biomarkers will constitute a public-domain resource for researchers and will be used toidentify and compare the effectiveness of new treatments and to define the state of the disease.Approximately $22 million in private-industry funding is projected to support this work.Alzheimer’s Disease Neuroimaging InitiativeBased on the precedent established by the Osteoarthritis Initiative, the Foundation is nowworking with the National Institute on Aging (NIA) and Foundation board memberDr. Steven Paul of Eli Lilly and Company to establish the Alzheimer’s Disease NeuroimagingInitiative. The initiative will be a partnership among NIA, the Foundation for NIH, theFood and Drug Administration, academic investigators, the pharmaceutical industry, andthe imaging equipment industry, with participation by the Alzheimer’s Association and theInstitute for the Study of Aging.The initiative will facilitate evaluation of biomarkers for the onset and progression of mildcognitive impairment and Alzheimer’s disease. A primary goal is to identify the biomarkers ofdisease progression that are most promising for use as surrogate endpoints in phase two andthree clinical trials for prevention and treatment of Alzheimer’s disease.Five-year funding of $2.5 million has already been secured from Eli Lilly, and additionalpledges totaling more than $7.5 million are under discussion, putting the program on trackto meet the overall target goal of $20 million in private contributions. Three additional newimaging-focused partnerships, also based on the OAI model, are currently in developmentfor 2004.EXPANDING BOUNDARIES FOR HUMAN HEALTHFOUNDATION FOR THE National Institutes of Health, Inc. 5

2003Annual ReportClinical Center Roundtable Discussion on Stroke — Internet VideoOn-line, on-demand availability of an experts’ video discussion, Stroke: Diagnosis,Prevention, and Treatment, commenced last June on the World Medical Leaders Web site,http://www.wml.com. The aim is to make the vital work of NIH researchers available to thepublic for the benefit of patients worldwide. This initial video discussion is a pilot project fora prospective discussion series. If enough interest is generated in the physician community,more roundtable discussions on other key subjects will follow.The pilot program is jointly presented by the Foundation for NIH in collaboration with WorldMedical Leaders, a multi-media distance learning company. The NIH and the Foundation forAdvanced Education in the Sciences designated this educational activity for credit toward theAmerican Medical Association Physician’s Recognition Award. The pilot video was moderatedby Steven Warach, M.D., Ph.D., chief of the Section on Stroke Diagnostics and Therapeuticsand senior investigator at the National Institute of Neurological Disorders and Stroke. Panelistsincluded Marian LaMonte, M.D., M.S.N., director of the Brain Attack Team and assistantprofessor of medicine at the University of Maryland Medical Center in Baltimore; J. P. Mohr,M.D., Sciarra professor of clinical neurology at the Neurological Institute of Columbia-Presbyterian Medical Center in New York City; and Philip B. Gorelick, M.D., M.P.H.,professor of neurological sciences at Rush Medical Center in Chicago.6 FOUNDATION FOR THE National Institutes of Health, Inc.EXPANDING BOUNDARIES FOR HUMAN HEALTH

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportINDEPENDENT AUDITOR’S REPORTkw&s KAMEROWWEINTRAUB& SWAIN,LLPCertified Public Accountants and Business Advisors11400 Rockville Pike, Suite 800Rockville, MD 20852-3004Phone: 301/468-2424 • Fax: 301/468-2480Email: consult@kwscpa.com • www.kwscpa.comTO THE BOARD OF DIRECTORSFoundation for the National Institutes of Health, Inc.Bethesda, MarylandWe have audited the accompanying balance sheets of the Foundation for the NationalInstitutes of Health, Inc. (a not-for-profit organization) as of December 31, 2003 and 2002,and the related statements of activities and cash flows for the years then ended. These financialstatements are the responsibility of the Foundation's management. Our responsibility is toexpress an opinion on these financial statements based on our audits.We conducted our audits in accordance with U.S. generally accepted auditing standards.Those standards require that we plan and perform the audit to obtain reasonable assuranceabout whether the financial statements are free of material misstatement. An audit includesexamining, on a test basis, evidence supporting the amounts and disclosures in the financialstatements. An audit also includes assessing the accounting principles used and significantestimates made by management, as well as evaluating the overall financial statementpresentation. We believe that our audits provide a reasonable basis for our opinion.In our opinion, the financial statements referred to above present fairly, in all materialrespects, the financial position of the Foundation for the National Institutes of Health, Inc. asof December 31, 2003 and 2002 and the changes in its net assets and its cash flows for theyears then ended in conformity with U.S. generally accepted accounting principles.March 30, 2004EXPANDING BOUNDARIES FOR HUMAN HEALTHFOUNDATION FOR THE National Institutes of Health, Inc. 7

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportBALANCE SHEETS - December 31, 2003 and 20022003 2002ASSETSCURRENT ASSETSCash and cash equivalents $7,596,289 $5,827,669Appropriations receivable 196,000 497,000Pledges receivable, less allowance for uncollectiblepledges receivable of $15,000 in 2003 and $30,000 in 2002 5,126,998 2,532,632Grants receivable 97,215 –Other receivables 10,087 100Accrued interest 53,981 10,775Prepaid expenses 22,000 –Total Current Assets 13,102,570 8,868,176PLEDGES RECEIVABLES 1,786,385 1,290,798INVESTMENTS 204,461,910 4,285,529FURNITURE AND EQUIPMENT, less accumulateddepreciation of $70,097 in 2003 and $51,830 in 2002 119,468 44,685Total Assets $219,470,333 $14,489,188LIABILITIES AND NET ASSETSCURRENT LIABILITIESAccounts payable $2,447,026 $60,417Accrued expenses 33,683 15,882Funds held for others - agency transactions 3,155,802 2,300,000Note payable - line of credit 500,000 1,860,000Total Current Liabilities 6,136,511 4,236,299DEFERRED GRANT REVENUE 198,936,983 –Total Liabilities 205,073,494 4,236,299NET ASSETSUnrestricted 1,700,178 1,185,513Temporarily restricted 9,493,112 5,971,449Permanently restricted 3,203,549 3,095,927See accompanying notes.Total Net Assets 14,396,839 10,252,889Total Liabilities And Net Assets $219,470,333 $14,489,1888 FOUNDATION FOR THE National Institutes of Health, Inc.EXPANDING BOUNDARIES FOR HUMAN HEALTH

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportSTATEMENT OF ACTIVITIES - Year Ended December 31, 2003Temporarily PermanentlyUnrestricted Restricted Restricted TotalREVENUEContributions $188,072 $10,068,894 $7,622 $10,264,588Grants 1,082,876 – – 1,082,876In-kind contributions 113,569 – – 113,569Government appropriations 496,000 – – 496,000Donated services 365,966 – – 365,966Interest revenue 65,174 42,325 – 107,499Administrative fee -agency transactions and grants 213,299 – – 213,299Miscellaneous 7,626 – – 7,626Net assets released from restrictions:Satisfaction of administrativefee requirements 426,238 (426,238) – –Satisfaction of program restrictions 6,063,318 (6,063,318) – –Total Revenue 9,022,138 3,621,663 7,622 12,651,423EXPENSESPROGRAM SERVICES:Fellowships and training programs 738,290 – – 738,290Memorials, awards and events 121,295 – – 121,295Capital projects 836,848 – – 836,848Research partnerships 2,779,092 – – 2,779,092Emerging areas 2,743,965 – – 2,743,965Total Program Services 7,219,490 – – 7,219,490SUPPORTING SERVICES:Management and general 1,176,366 – – 1,176,366Fundraising 111,617 – – 111,617Total Supporting Services 1,287,983 – – 1,287,983Total Expenses 8,507,473 – – 8,507,473Change In Net Assets 514,665 3,621,663 7,622 4,143,950NET ASSETS AT BEGINNING OF YEAR 1,185,513 5,971,449 3,095,927 10,252,889TRANSFERS – (100,000) 100,000 –See accompanying notes.Net Assets At End Of Year $1,700,178 $9,493,112 $3,203,549 $14,396,839EXPANDING BOUNDARIES FOR HUMAN HEALTHFOUNDATION FOR THE National Institutes of Health, Inc. 9

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportSTATEMENT OF ACTIVITIES - Year Ended December 31, 2002Temporarily PermanentlyUnrestricted Restricted Restricted TotalREVENUEContributions $97,898 $7,382,665 $808,290 $8,288,853Grants 25,000 – – 25,000In-kind contributions 24,299 – – 24,299Government appropriations 997,000 – – 997,000Donated services 133,591 – – 133,591Interest revenue 145,261 62,683 – 207,944Administrative fee -agency transactions and grants 121,500 – – 121,500Miscellaneous 6,743 – – 6,743Net assets released from restrictions:Satisfaction of administrativefee requirements 189,497 (189,497) – –Satisfaction of program restrictions 6,672,401 (6,672,401) – –Total Revenue 8,413,190 583,450 808,290 9,804,930EXPENSESPROGRAM SERVICES:Fellowships and training programs 862,492 – – 862,492Memorials, awards and events 212,973 – – 212,973Capital projects 6,067,528 – – 6,067,528Research partnerships 100,046 – – 100,046Total Program Services 7,243,039 – – 7,243,039SUPPORTING SERVICES:Management and general 784,112 – – 784,112Fundraising 160,423 – – 160,423Total Supporting Services 944,535 – – 944,535Total Expenses 8,187,574 – – 8,187,574Change in Net Assets 225,616 583,450 808,290 1,617,356NET ASSETS AT BEGINNING OF YEAR 959,897 5,387,999 2,287,637 8,635,533Net Assets at End of Year $1,185,513 $5,971,449 $3,095,927 $10,252,889See accompanying notes.10 FOUNDATION FOR THE National Institutes of Health, Inc.EXPANDING BOUNDARIES FOR HUMAN HEALTH

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportSTATEMENTS OF CASH FLOWS - Years Ended December 31, 2003 and 20022003 2002CASH FLOWS FROM OPERATING ACTIVITIESChange in net assets $4,143,950 $1,617,356Adjustments to reconcile change in net assets tonet cash provided (used) by operating activities:Depreciation 18,267 16,829Contributions restricted for long-term purposes (7,622) (808,290)Bad debt expense – 30,000(Increase) decrease in:Appropriations receivable 301,000 (497,000)Pledges receivable (3,089,953) (1,812,118)Grants receivable (97,215) –Other receivables (9,987) 1,830Accrued interest (43,206) (1,371)Prepaid expenses (22,000) 385Increase (decrease) in:Accounts payable 2,386,609 46,597Accrued expenses 17,801 (169,468)Funds held for others - agency transactions 855,802 (1,750,000)Deferred grant revenue 198,936,983 –Net Cash Provided (Used) by Operating Activities 203,390,429 (3,325,250)CASH FLOWS FROM INVESTING ACTIVITIESPurchases of furniture and equipment (93,050) (19,901)Purchases of investments (598,156,691) (70,112)Proceeds from sales of investments 397,980,310 –Net Cash Used by Investing Activities (200,269,431) (90,013)CASH FLOWS FROM FINANCING ACTIVITIESProceeds from contributions restricted for:Investment in permanent endowment 7,622 808,290Proceeds from note payable - line of credit 500,000 1,860,000Payments on note payable - line of credit (1,860,000) –Net Cash Provided (Used) by Financing Activities (1,352,378) 2,668,290Net Increase (Decrease) in Cash andCash Equivalents 1,768,620 (746,973)Cash and Cash Equivalentsat Beginning of Year 5,827,669 6,574,642Cash and Cash Equivalentsat End of Year $7,596,289 $5,827,669SUPPLEMENTAL DISCLOSURESCash paid during the year for:Interest $16,185 $2,224Income taxes – –See accompanying notes.EXPANDING BOUNDARIES FOR HUMAN HEALTHFOUNDATION FOR THE National Institutes of Health, Inc. 11

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportNOTES TO FINANCIAL STATEMENTS - December 31, 2003 and 2002NOTE A - Nature of Activites and Summary of Significant Accounting PoliciesNature of ActivitiesThe Foundation for the National Institutes of Health, Inc. (the Foundation) is a not-for-profitorganization whose mission is to support the National Institutes of Health (NIH) in its mission,and to advance collaboration with biomedical researchers from universities, industry, andnonprofit organizations.Basis of AccountingThe financial statements of the Foundation have been prepared on the accrual basis of accounting and,accordingly, reflect all significant receivables, payables, and other liabilities.Financial Statement PresentationFinancial statement presentation follows the recommendations of the Financial Accounting StandardsBoard in its Statement of Financial Accounting Standards (SFAS) No. 117, "Financial Statements ofNot-for-Profit Organizations." Under SFAS No. 117, the Foundation is required to report informationregarding its financial position and activities according to three classes of net assets: unrestricted netassets, temporarily restricted net assets, and permanently restricted net assets. In addition, theFoundation is required to present a statement of cash flows.EstimatesThe preparation of financial statements in conformity with U.S. generally accepted accounting principlesrequires management to make estimates and assumptions that affect certain reported amounts anddisclosures. Accordingly, actual results could differ from those estimates.Cash and Cash EquivalentsFor purposes of the financial statement presentation, cash and cash equivalents includes all cash on hand,demand accounts, and highly-liquid investments with original maturities of three months or less forwhich it is not the intention of management to hold for long-term purposes.Pledges and Appropriations ReceivablesUnconditional pledges receivable that are expected to be collected within one year are recorded at netrealizable value. Unconditional pledges to be collected in more than one year are recorded at net presentvalue, which approximates fair value. Conditional pledges receivable are recognized when the conditionson which they depend are substantially met. Appropriations receivable are recorded at theappropriated amount.Allowance for Uncollectible ReceivablesManagement has established an allowance for uncollectible pledges receivable in the amount of $15,000as of December 31, 2003 and $30,000 as of December 31, 2002, based on a review of historicalcollections. Amounts recorded as appropriations, grants and other receivables are deemed to be fullycollectible by management. Accordingly, an allowance has not been recorded for those receivables.12 FOUNDATION FOR THE National Institutes of Health, Inc.EXPANDING BOUNDARIES FOR HUMAN HEALTH

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportNOTES TO FINANCIAL STATEMENTS - December 31, 2003 and 2002NOTE A - Nature of Activites and Summary of Significant Accounting Policies (continued)InvestmentsInvestments are recorded at market value. When applicable, gains or losses are recognized upon sale ordisposal. For the years ended December 31, 2003 and 2002, the market value of the investmentsapproximated cost.Furniture and EquipmentFurniture and equipment are recorded at cost less accumulated depreciation. Depreciation iscomputed using the straight-line method over the estimated useful lives of the assets, which is fiveyears. It is the Foundation's policy to capitalize purchases of furniture and equipment that cost$1,000 or more. Donated equipment is recorded at fair market value at the date of contribution.ContributionsIn accordance with SFAS No. 116, "Accounting for Contributions Received and ContributionsMade," contributions received are recorded as unrestricted, temporarily restricted, or permanentlyrestricted revenue depending on the existence and/or nature of any donor restrictions. Donorrestrictedrevenue is reported as an increase in temporarily or permanently restricted net assets,depending on the nature of the restriction. When a restriction expires (that is, when a stipulatedtime restriction ends or purpose restriction is accomplished), temporarily restricted net assets arereclassified to unrestricted net assets and reported in the statements of activities as net assets releasedfrom restrictions.The Foundation follows the accounting principles required under SFAS No. 136, "Transfers of Assetsto a Not-for-Profit Organization or Charitable Trust That Raises or Holds Contributions for Others."Accordingly, any assets received by the Foundation for which the donor stipulates that the assets areto be used on behalf of the donor or another entity (the beneficiary) or to be transferred to anotherentity are recorded on the Foundation’s books as a liability to the specified beneficiary concurrentwith recognition of the assets received from the donor.Revenue RecognitionGovernment appropriations are recognized as revenue in the year they are appropriated.Allocation of ExpensesSalaries and benefits have been allocated to program and supporting services based on estimates madeby management.Income TaxesThe Foundation has been granted an exemption from federal income taxes under Section 501(c)(3)of the Internal Revenue Code and is classified by the Internal Revenue Service as other than aprivate foundation.EXPANDING BOUNDARIES FOR HUMAN HEALTHFOUNDATION FOR THE National Institutes of Health, Inc. 13

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportNOTES TO FINANCIAL STATEMENTS - December 31, 2003 and 2002NOTE B - Cash and Cash EquivalentsAs of December 31, 2003, the Foundation had bank deposits in excess of federally insured limits.NOTE C - Pledges ReceivableAs of December 31, 2003 and 2002, unconditional pledges receivable consisted of the following:2003 2002Receivable in less than one year $5,141,998 $2,562,632Receivable in one to five years 1,900,000 1,402,840TOTAL 7,041,998 3,965,472Less: discounts to net present valueusing a discount rate of 4% - 8.25% 113,615 112,042Less: allowance for uncollectiblepledges receivable 15,000 30,000NOTE D - InvestmentsTOTAL PLEDGES RECEIVABLE $6,913,383 $3,823,430Investments held by the Foundation consisted of the following as of December 31, 2003:CostMarketValueMoney market accounts $ 204,363,094 $ 204,363,094Bonds 98,816 98,816Balance, December 31, 2003 $ 204,461,910 $ 204,461,910Investments held by the Foundation consisted of the following as of December 31, 2002:CostMarketValueMoney market accounts $ 4,285,529 $ 4,285,529Balance, December 31, 2002 $ 4,285,529 $ 4,285,529Investment interest revenue, which is included in interest revenue on the statements of activities, equaled$70,897 and $70,113 for the years ended December 31, 2003 and 2002, respectively. There were norealized or unrealized gains or losses for the years ended December 31, 2003 and 2002.14 FOUNDATION FOR THE National Institutes of Health, Inc.EXPANDING BOUNDARIES FOR HUMAN HEALTH

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportNOTES TO FINANCIAL STATEMENTS - December 31, 2003 and 2002NOTE E - Temporarily Restricted Net AssetsAs of December 31, 2003 and 2002, temporarily restricted net assets were available for thefollowing purposes:2003 2002The Neuroscience Fellowship Program $70,114 $70,114Clinical Research Training Program 2,251,039 1,084,014Norman P. Salzman Memorial Fund 6,089 96,108From Genome to Disease: A Symposium of HighThroughput Biology 15,915 10,000Robert Whitney Newcomb Memorial Fund 163,696 142,565Graduate Student Lounge 48,397 48,397Sallie Rosen Kaplan Fellowship for Women Scientistsin Cancer Research 20,421 19,603Multilateral Initiative on Malaria 170,538 165,900The Intolerable Burden of Malaria II: What’s New, What’s Needed 49,163 -Celebrating 50 Years of Brain Research: New Discoveries,New Hope 402,340 220,576Pain and Palliative Care Program 51,674 58,342Clinical Research Training Program Alumni Reunion 23,540 50,002Cancer Research 4,753 4,998NCI Division of Clinical Services HIV/AIDS Malignancy 15,000 15,000Fogarty International Center 35th Anniversary:Science for Global Health 12,149 61,239The Genetic Code Revisited:The Impact of Functional Genomics in Medical Research 17,984 18,209The Helix and the Genome: 50 Years from Model to Medicine 68,898 387,775Best Pharmaceuticals for Children Fund 3,360,218 1,557,797Overcoming Barriers to Early Phase Clinical Trials 1,416,142 1,948,675Adam J. Berry Memorial Fund 1,983 975Lloyd Law Memorial Fund 425 425The Sayer Vision Research Fund 42,150 1,000Miscellaneous Scientific Events 6,592 6,592Vaccine Research Center Community Meeting 4,743 3,143Vaccine Research Center Community Advisory Board 7,900 -Alzheimer’s Disease Neuroimaging Initiative 499,959 -Allogeneic Stem Cell Transplantation Seminar andSurvivorship Celebration 5,698 -Dean R. O’Neill Renal Cell Cancer Research Fund 28,170 -Methods for Enhancing the Efficiency of Dental/Oral HealthClinical Trails: Current Status, Future Directions 29,300 -Innovation in Prevention Awards 557,121 -The National Center for Complementary andAlternative Medicine Director’s Fellowship Program 75,000 -A Symposium in Honor of Martha Vaughn:Insights into Signal Transduction 13,000 -Conference on Dietary Supplement Use in the Elderly 8,902 -Oxford University and Cambridge University-National Institutesof Health Scholars in Biomedical Sciences 20,000 -VaxGen Vaccine Trial in Thailand 23,395 -Viral Hemorrhagic Fevers Symposium 704 -TOTAL $9,493,112 $5,971,449EXPANDING BOUNDARIES FOR HUMAN HEALTHFOUNDATION FOR THE National Institutes of Health, Inc. 15

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportNOTES TO FINANCIAL STATEMENTS - December 31, 2003 and 2002NOTE F - Permanently Restricted Net AssetsPermanently restricted net assets consist of endowment fund assets to be held indefinitely. Theearnings from these assets are to be used for the purposes established by the donors and arerecorded as temporarily restricted interest revenue for those purposes.As of December 31, 2003 and 2002, permanently restricted net assets consisted of the followingendowed gifts to be held in perpetuity with the income to be used for:2003 2002Edmond J. Safra Family Lodge $2,315,777 $2,308,155Sallie Rosen Kaplan Fellowship forWomen Scientists in Cancer Research 787,772 787,772Norman P. Salzman Memorial Fund 100,000 -TOTAL $3,203,549 $3,095,927NOTE G - Donated ServicesThe Foundation receives benefit from services donated by the NIH, which include variousadministrative and technical services performed by NIH employees. The estimated value of theseservices is based on the hourly rate and average benefit amount of the NIH employee. The estimatedamount of these services has been reflected in the accompanying financial statements as donatedservices with a like amount recorded as salaries and benefits expense.The Foundation also receives benefit from donated legal services. The value of these services has beenreflected in the financial statements as donated services with a like amount recorded as professionalfees expense.For the year ended December 31, 2003, the Foundation received donated services for the design ofthe Edmond J. Safra Family Lodge garden. The value of these services has been reflected in thefinancial statements as donated services with a like amount recorded as consultants expense.For the years ending December 31, 2003 and 2002, donated services of $365,966 and $133,591,respectively, are reflected in the financial statements.16 FOUNDATION FOR THE National Institutes of Health, Inc.EXPANDING BOUNDARIES FOR HUMAN HEALTH

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportNOTES TO FINANCIAL STATEMENTS - December 31, 2003 and 2002NOTE H - In-Kind ContributionsOffice space for the Foundation is donated by the NIH. This space expanded during the year endedDecember 31, 2003. The estimated rental value is determined by the current market rent for otheroffices within the buildings. The Foundation also received donated on-line communication costsbeginning during the year ended December 31, 2003. The estimated rental value and value of thecommunication costs has been reflected in the accompanying financial statements as in-kindcontributions with a like amount recorded as rent/housing expense or communications expense. Forthe years ending December 31, 2003 and 2002, in-kind contributions of $113,569 and $24,299,respectively, are reflected in the financial statements.NOTE I - Retirement PlanThe Foundation has a retirement plan through TIAA-CREF. The plan calls for a mandatorycontribution of at least 2% of annual salary from participating employees and an additionalcontribution of 10% of annual salary from the Foundation. Pension expense for the years endedDecember 31, 2003 and 2002 was $66,881 and $39,895, respectively.NOTE J - Concentration of RevenueFor the year ended December 31, 2003, the Foundation received approximately 26% of itsrevenue from contributions and grants from the Bill & Melinda Gates Foundation. For the yearended December 31, 2002, the Foundation received approximately 30% of its revenue fromcontributions from The Edmond J. Safra Philanthropic Foundation.NOTE K - Memorandum of UnderstandingThe Foundation was established under legislation that authorized it to be the sole entityresponsible for soliciting funds on behalf of the NIH, and to conduct specific other activitiesthat support the NIH in its mission. Certain of the activities described in the legislation areconducted by the Foundation for the Advanced Education in the Sciences, Inc. (FAES) under aMemorandum of Understanding (MOU) with the Foundation. This MOU preserves theprerogatives conferred on the Foundation by its authorizing legislation but also allows the FAESto carry on its current activities under the authority of the Foundation.NOTE L - Reclassifications of Net Assets And TransfersIn the normal course of business, the Foundation often receives contributions in which there is adelay between when the contribution is received and the time when the donor and theFoundation finalize the donor restrictions or other matters affecting the treatment of thecontribution. The results of these negotiations determine the ultimate accounting classificationfor these funds. Because of this situation, certain reclassifications of contributions may need tobe recorded as terms, restrictions and conditions are finalized. For the year ended December 31,2003, any reclassifications of this type are shown as transfers on the statement of activities.There were no reclassifications of this type for the year ended December 31, 2002.EXPANDING BOUNDARIES FOR HUMAN HEALTHFOUNDATION FOR THE National Institutes of Health, Inc. 17

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportNOTES TO FINANCIAL STATEMENTS - December 31, 2003 and 2002NOTE M - Line of CreditThe Foundation entered into a commercial note with SunTrust Bank on September 24, 2002.A revolving line of credit was established with a limit of $2,300,000 for the purpose ofconstructing the Edmond J. Safra Family Lodge, located on the grounds of the NationalInstitutes of Health in Bethesda, Maryland.The line of credit is payable on demand and is secured by the Foundation’s pledges receivabledirected to the construction of The Edmond J. Safra Family Lodge and a blanket lien on allbusiness assets. The line of credit requires the Foundation to maintain an interest reserveaccount for the life of the loan and to not incur additional external debt. Interest on theoutstanding balance is due monthly at the 30-day indexed LIBOR plus 1.25%. The note can beprepaid and matures on September 24, 2004. As of December 31, 2003 and 2002, the loanbalance was $500,000 and $1,860,000, respectively, and is reflected in the balance sheets as notepayable - line of credit.NOTE N - ReclassificationsCertain reclassifications have been made to the 2002 financial statements to conform with the2003 financial statement presentation. Such reclassifications had no effect on the change in netassets as previously reported.18 FOUNDATION FOR THE National Institutes of Health, Inc.EXPANDING BOUNDARIES FOR HUMAN HEALTH

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportINDEPENDENT AUDITOR’S REPORT ON SUPPLEMENTARY INFORMATIONkw&s KAMEROWWEINTRAUB& SWAIN,LLPCertified Public Accountants and Business Advisors11400 Rockville Pike, Suite 800Rockville, MD 20852-3004Phone: 301/468-2424 • Fax: 301/468-2480Email: consult@kwscpa.com • www.kwscpa.comTo the Board of DirectorsFoundation for the National Institutes of Health, Inc.Bethesda, MarylandOur report on our audits of the basic financial statements of the Foundation for the National Institutes ofHealth, Inc. for the years ended December 31, 2003 and 2002 appears on page one. We conducted our auditsin accordance with U.S. generally accepted auditing standards for the purpose of forming an opinion on thebasic financial statements taken as a whole. The schedule of functional expenses is presented for purposes ofadditional analysis and is not a required part of the basic financial statements. Such information has beensubjected to the auditing procedures applied in the audits of the basic financial statements and, in our opinion,is fairly stated in all material respects in relation to the basic financial statements taken as a whole.March 30, 2004EXPANDING BOUNDARIES FOR HUMAN HEALTHFOUNDATION FOR THE National Institutes of Health, Inc. 19

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportSCHEDULE OF FUNCTIONAL EXPENSESYear Ended December 31, 2003With Comparative Totals for 2002Program ServicesFellowships Memorials,and Training Awards and Capital ResearchPrograms Events Projects PartnershipsSalaries and benefits $44,526 $3,312 $6,414 $234,602Stipends 445,875 2,500 - -Program contracts 25,000 - 500,000 1,297,286Meetings and conferences 46,814 3,424 192 188,755Office supplies and expense - - - 1,920Telephone - - - 503Books and supplies 16,842 - - 2,688Tuition 2,590 310 - -Insurance 36,544 - - 2,237Consultants 1,760 11,601 310,033 586,266Professional fees - - - 97,057Special events - 59,367 - 69,948Travel 26,538 90 370 53,817Depreciation - - - -Rent/housing 48,824 - - 28,275Recruiting 7,955 - - 200Relocation 10,552 - - -Temporary services - - - -Dues and subscriptions - - - 100Equipment rental and maintenance - - - 19,688Printing and photocopying - 40,656 - 2,834Postage and delivery 89 35 86 3,237Service charges - - 3,487 -Subcontracts - - - 1,861Interest expense - - 16,185 -Bad debt expense - - - -Communications 3,346 - - 84,484Advertising and promotion - - - 98,515Miscellaneous 21,035 - 81 4,819TOTAL EXPENSES $738,290 $121,295 $836,848 $2,779,09220 FOUNDATION FOR THE National Institutes of Health, Inc.EXPANDING BOUNDARIES FOR HUMAN HEALTH

FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportEmergingAreasTotalProgramServicesSupporting ServicesTotalManagement Supporting 2003 2002and General Fundraising Services Total Total$21,590 $310,4444,000 452,3752,241,234 4,063,520437,957 677,142- 1,920- 503- 19,530- 2,900236 39,017- 909,660- 97,05735,949 165,2641,307 82,122- -- 77,099- 8,155- 10,552- -- 100- 19,688350 43,840298 3,74544 3,531- 1,861- 16,185- -- 87,830- 98,5151,000 26,935$2,743,965 $7,219,490$730,518 $72,158 $802,676 $1,113,120 $586,854- - - 452,375 428,724- - - 4,063,520 6,098,56216,767 4,106 20,873 698,015 254,21616,180 219 16,399 18,319 15,2752,196 122 2,318 2,821 1,3897,624 - 7,624 27,154 31,45810,745 668 11,413 14,313 6,17346,046 - 46,046 85,063 74,63967,719 10,658 78,377 988,037 111,71868,545 - 68,545 165,602 113,67635 - 35 165,299 83,4698,052 4,348 12,400 94,522 37,27018,267 - 18,267 18,267 16,82921,564 - 21,564 98,663 89,097- - - 8,155 7,009- - - 10,552 12,1505,820 480 6,300 6,300 19,5096,042 2,900 8,942 9,042 16,6239,917 - 9,917 29,605 6,57432,415 6,808 39,223 83,063 54,9604,524 4,615 9,139 12,884 8,50633,137 - 33,137 36,668 38,884- 4,127 4,127 5,988 7,200- - - 16,185 2,224- - - - 30,00062,229 - 62,229 150,059 -2,400 - 2,400 100,915 -5,624 408 6,032 32,967 34,586$1,176,366 $111,617 $1,287,983 $8,507,473 $8,187,574EXPANDING BOUNDARIES FOR HUMAN HEALTHFOUNDATION FOR THE National Institutes of Health, Inc. 21

The following partners have made theFoundation’s programs possible.FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTHFinancial Statements with Supplementary Information and Independent Auditor’s ReportWE ARE GRATEFUL FOR THEIR SUPPORT AND INVOLVEMENTADAM J. BERRY MEMORIAL FUNDStuart M. Berger and Timothy J. LearyJacob I. and Thelma GinsbergDennis R. and Jennifer B. GoldensonPaul GromanEdward and Diane McDowellLori A. RolnickMr. Norman RolnickMr. and Mrs. Steven R. RolnickDenise P. Simmons, Ph.D.Danielle E. SimmonsJudith TreesbergALLOGENEIC STEM CELL TRANSPLANTATIONSEMINAR AND SURVIVORSHIP CELEBRATIONAmgen, Inc.Berlex Laboratories, Inc.A past patient in the NHLBI transplantationprogram, his stem cell donor, and his caregivers,on behalf of all patientsBIOMEDICAL ENGINEERING SUMMERINTERNSHIP PROGRAMThe Whitaker FoundationBEST PHARMACUETICALS FOR CHILDREN FUNDAstraZeneca LPAventis Pharmaceuticals Inc.Eli Lilly and Company FoundationGlaxoSmithKlineJohnson & Johnson Inc.The Merck Company FoundationMillennium Pharmaceuticals, Inc.RocheWyethCANCER RESEARCHJEAN-CLAUDE ANGERS MEMORIALAlexandre V. Abrantes and Renato ZaratzJohanne AngersGhislaine Baghdadi-AkaSafaa El-KogaliNicole M. HamonDaniele JaekelJohn May and Anne May-LegrandCLINICAL RESEARCH TRAINING PROGRAMPfizer Pharmaceuticals GroupCLINICAL INVESTIGATOR STUDENT TRAINEE FORUMDoris Duke Charitable FoundationPfizer Pharmaceuticals GroupCONFERENCE ON DIETARY SUPPLEMENT USEIN THE ELDERLYAmerican College of Clinical PharmacologyCatholic Health Association22 FOUNDATION FOR THE National Institutes of Health, Inc.Cognis CorporationInternational Food Information Council FoundationNational Dairy CouncilNSF InternationalVirgo Publishing Inc.JOHN LAWS DECKER MEMORIAL FUNDLucille Decker & the Decker FamilyEDMOND J. SAFRA FAMILY LODGEMary G. Balow’s Home Team AdvantageThe Honorable and Mrs. William McCormick Blair, Jr.Peggy and Jack Gerlacher in memory of Danny HillDr. and Mrs. Harry L. MalechDr. and Mrs. Paul M. MontroneThe Edmond J. Safra Philanthropic FoundationWalter and Nina WeinerRobert and Janice WeymouthWinthrop, Inc.JOHN I. AND ELAINE K. GALLIN ENDOWMENTArthur J. Atkinson, Jr., M.D.Barry and Bobbi CollerDoris Duke Charitable FoundationElsevier, Inc. / Academic PressJohn I. Gallin, M.D., and Elaine K. Gallin, Ph.D.MICHAEL F. HALECKY MEMORIAL FUNDDiane M. and Glenn A. AsciuttoJanet HaleckyDrs. Samuel and Gina M. LacapraJohn D. and Rosemarie MarfleetDarren and Pamela RayCAROLINE DAWSON HELLER MEMORIAL FUNDDr. and Mrs. Eric BeauvoisJames J. DawsonJared C. and Amity Aldrich DawsonMary Louise DawsonChristopher A. HellerNEIL T. KINNEAR MEMORIAL FUNDLt. Susie GramppTerri Kerner in honor of Joel FriedmanMegan R. Kinnear in honor of Beth Kinnearon Mother’s DayMegan R. Kinnear in honor of Neil Kinnearon Father’s DayThomas E. and Constance VickeryROBERT SPENGLER MEMORIAL FUNDGlen and Barbara AndersonRobert C. and Betty A. BallFrank F. and Grace C. HooperBeth A. and Stanley J. KleisLinda K. RomineEXPANDING BOUNDARIES FOR HUMAN HEALTH

FOUNDATIONFOR THE National Institutes of Health, IncDONORSFOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTHFinancial Statements with Supplementary Information and Independent Auditor’s ReportEDMOND J. SAFRA FAMILY LODGE GARDENMadison Cox Design, Inc.The Edmond J. Safra Philanthropic FoundationCARL BRENNER MEMORIAL FUNDAnthony A. Athens and Debra MaltzMichael and Laura BaucumBrad BergmannEleanor L. BergmannHindi BergmannEugenia BertettiGlenn and Ann BiggsThe Honorable and Mrs. William McCormick Blair, Jr.Aubrey M. BrennerMarie Brenner PomerantzBroadway Brokerage Services, Inc.Josephine EstradaDennis EvansElla Zuschlag FischerMadelyn GoldfeinHarriet B. Gordon and FamilyVictor and Betsy GotbaumSuzanne C. and James D. GoudgeRobert J. and Sandra W. GrimmMr. and Mrs. Donald B. HarrellLeon and Linda HertzDavid HubbellDr. and Mrs. S. S. KalterWayne LawsonBernard Lee LifshutzHenry H. Livingston, IIIAimee Jeffers Locke and Stacy LockeJohn R. Locke, Jr.Robert S. MarvinNancy and Lucian MorrisonSusan R. OppenheimerRichard B. and Kathryn M. RoseKerry A. Rubin and Adam LeitnerEdward and Cheryl SachsPeter C. SeligStella E. Waugh, CCSWGeorge D. WeatherstonMr. and Mrs. George J. WechslerWillow Drive Nursery, Inc.Mr. and Mrs. Tom WinnDavid W. and Marianne S. WoodGeorge and Allison WoodFROM GENOME TO DISEASE: A SYMPOSIUM OFHIGH THROUGHPUT BIOLOGYAffymetrix, Inc.The American Physiological SocietyAmersham BiosciencesApplied BiosystemsCharles River LaboratoriesGenetixGlen Research CorporationInvitrogen CorporationLexicon Genetics IncorporatedEXPANDING BOUNDARIES FOR HUMAN HEALTHMerck & Co., Inc.The Midland Certified Reagent Co., Inc.Novartis Pharmaceuticals CorporationPerkinElmer InstrumentsPromega CorporationQiagen, Inc.Roche Applied ScienceSequenom, Inc.StratageneUnion Biometrica, Inc.THE HELIX AND THE GENOME: 50 YEARS FROMMODEL TO MEDICINEAARPAbbott LaboratoriesAffymetrix, Inc.Amgen, Inc.Applied BiosystemsBayer Healthcare PharmaceuticalsMr. and Mrs. David G. BradleyMr. and Mrs. William N. CafritzCancer Research and Prevention FoundationCare Capital LLCDr. and Mrs. James H. CavanaughEdvotekEli Lilly and Company FoundationFisher Scientific International Inc.Genentech, Inc.Genzyme CorporationGlaxoSmithKlineIBM Life SciencesIllumina, Inc.Lexicon Genetics IncorporatedLI-COR BiosciencesMerck & Co., Inc.Millennium Pharmaceuticals, Inc.NatureNew Enterprise AssociatesNovartis Institutes of Biomedical Research, Inc.Pfizer IncRho VenturesRocheSchering-Plough Research InstituteSeqWrightSlatkin & Co.Vertex Pharmaceuticals, Inc.WyethHUMAN PAPILLOMA VIRUS CLINICAL TRIALGlaxoSmithKline BiologicalsINNOVATION IN PREVENTION AWARDSAbbott LaboratoriesAmerican Association of Health Plans-Health InsuranceAssociation of AmericaAstraZeneca LPBristol-Myers SquibbThe Coca-Cola CompanyFOUNDATION FOR THE National Institutes of Health, Inc. 23

The following partners have made theFoundation’s programs possible.FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportWE ARE GRATEFUL FOR THEIR SUPPORT AND INVOLVEMENTEli Lilly and CompanyGlaxoSmithKlineGrocery Manufacturers of AmericaH.J. Heinz Company FoundationKraft FoodsMars IncorporatedNestlé USANovartis Pharmaceuticals CorporationPepsiCoPfizer IncPhRMARodale Inc.The Susan G. Komen Breast Cancer FoundationLLOYD LAW MEMORIAL FUNDDr. and Mrs. Richard M. BergenstalJ. Douglas Leslie and Barbara S. ClarkeTHE INTOLERABLE BURDEN OF MALARIA II:WHAT’S NEW, WHAT’S NEEDEDBurroughs Wellcome FundThe Rockefeller FoundationSwiss Agency Development & CooperationWorld Health Organization - AFROTHE NATIONAL CENTER FOR COMPLEMENTARY ANDALTERNATIVE MEDICINE DIRECTOR’S FELLOWSHIP PROGRAMThe Prince of Wales FoundationTHE NEUROSCIENCE FELLOWSHIP PROGRAMEli Lilly and CompanyDEAN R. O’NEILL RENAL CELL CANCER RESEARCH FUNDJessica R. ArnoldBAE SystemsDonald J. and Ann C. BergAmanda E. BrezinerRobert L. and Patty M. BrowneVirginia L. CareyThe Clark Construction Group, Inc.David B. and Rachel L. CookeAndrew B. and Krista K. CurtissRebecca L. DillingMr. and Mrs. R. P. DraimPeter L. DresselMina Charles FaltasCraig J. and Rachel B. FlanaganByron T. and Evelyn L. FoltzKathryn and John G. ForrestKenneth and Kelly FoxSalvatore N. Gallodoro, IIIGeorge F. and Margaret E. GormanGlenn and Cheryl GrayEdward T. and Adelaide H. GruelPamela M. and H.S. Meade GwinnDean A. and Dixie K. HarveyHomeTeam Pest Defense, LLCAmy M. and Gary M. Howard24 FOUNDATION FOR THE National Institutes of Health, Inc.Kathryn T. JacobsonCatherine S. JenningsL. Kenneth Johnson, Jr.Allison R. JonesJohn A. and Cori E. JorgensenNiels A. and Susan R. JorgensenThomas W. and Sharon D. KallioMary M. LyerlyDavid W. MarshallD. P. MattokKatie M. McCormickGreg C. and Holly H. McLendonDeborah G. and Richard B. MilliganVirginia and William MooreWilliam A. and Janice M. MooreGordon L. and Kathleen P. MoranJeanne M. Murphy and Joyce A. MurphySusan G. MustAdam Thomas MyersJennifer L. NascholdStacey L. NelsonMr. Gerald J. NissenCecilia Y. OhBrian R. O’NeillKevin and Tara O’NeillMatthew W. O’NeillSusan O’NeillHarrish J. and Mattie C. ParrishJennifer PerryCarl D. and Janna L. PinckneyM. Bridget PinePlanning Systems, Inc.Paul E. and Maria C. PressleyMelanie G. PrzybockiRobert C. DeHaven Enterprises, LLCMahsa SaeedpourMehul P. SanghaniSpencer B. and Cheryl L. ScheelerDonna C. SheltonAnne R. SieversJay W. SilvermanMary R. SireneJennifer L. TortoraRichard D. and Wenda K. TraversJanelle VarleyElsie M. Whalen and Elyse M. DeBonisThomas E. and Marcia G. WilsonOVERCOMING BARRIERS TO EARLY PHASE CLINICAL TRIALSAventis Pharmaceuticals Inc.Bristol-Myers Squibb CompanyEli Lilly and CompanyFriends of Cancer ResearchGlaxoSmithKlineNovartis Pharmaceuticals CorporationOSTEOARTHRITIS INITIATIVEMerck & Co., Inc.Novartis Pharmaceuticals CorporationPfizer IncEXPANDING BOUNDARIES FOR HUMAN HEALTH

FOUNDATIONFOR THE National Institutes of Health, IncDONORSFOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTHFinancial Statements with Supplementary Information and Independent Auditor’s ReportOXFORD UNIVERSITY AND CAMBRIDGE UNIVERSITY-NATIONAL INSTITUTES OF HEALTH SCHOLARS INBIOMEDICAL SCIENCESDr. and Mrs. Mahlon R. DeLongDr. and Mrs. Michael M. GottesmanDr. Michael J. Lenardo and Ms. Lesley A. FurlongJoan P. Schwartz, Ph.D. and Ronald H. SchwartzPAIN & PALLIATIVE CARE PROGRAMGene and Lawrence Friedman in honorDr. Paul TurkeltaubOrtho Biotech Products, LPROBERT WHITNEY NEWCOMB MEMORIAL FUNDMr. and Mrs. Don C. HardestyDorothy O. Newcomb TrustNORMAN P. SALZMAN MEMORIAL FUNDDr. and Mrs. Morton DavisDr. and Mrs. Robert S. FlaumPeggy and Jack GerlacherDavid and Lori HurwitzDr. Steve JacobsDr. Roma KaufmannLeonard I. and Gerrie PearlinJoseph and Evelyn ReaderLenore R. SalzmanRobert W. and Glenna R. SimpsonUniversity Hospitals Health System in honorof Dr. H. Clifford LaneDr. George F. Vande WoudeJANE M. SAYER VISION RESEARCH FUNDMrs. Calvin D. LintonJane M. Sayer, Ph.D.VIRAL HEMORRHAGIC FEVERS SYMPOSIUMAnonymousGenVec, Inc.VACCINE RESEARCH CENTER ADVISORY BOARDLipid Sciences, Inc.VACCINE RESEARCH CENTER COMMUNITY MEETINGInternational AIDS Vaccine Initiative Inc.ALL FNIH PROGRAMSAnonymousDr. and Mrs. Itamar B. AbrassMelanie D. AdamsonDr. and Mrs. David H. AlpersDr. Peter S. Aronson and Ms. Marie LandryArthur J. Atkinson, Jr., M.D.Gary and Sharon BarbarashDr. and Mrs. Paul BergThe Honorable and Mrs. William McCormick Blair, Jr.Dr. Terezinha P. BoundsLuther W. Brady, M.D.Dr. and Mrs. Samuel E. BroderBrian Butters and Ellen FarrellDr. Virgil R. CarlsonDr. Gail H. Cassell and Mr. Ralph H. CassellDr. and Mrs. Howard CedarDiana L. ChatfieldCatherine A. ChristopherColleen A. ClancyDr. Yank D. CobleTheodore R. Colburn, Ph.D.Dr. and Mrs. Robert B. CouchLloyd N. Cutler, EsquireThe Dallas Basketball Booster Club in honor ofMichael J. FultonYolanda DebyleDesign CuisineDarryl C. De Vivo, M.D.Michael S. Duchowny, M.D.Mark D. EinDrs. Howard Jay Eisen and Judith E. WolfDr. Richard D. EnglandAnthony S. Fauci, M.D.Michelle A. FitzpatrickBrooke FoxDr. and Mrs. Thomas W. FoxDr. Arthur E. FrankelDr. Joseph F. Fraumeni, Jr.Fried, Frank, Harris, Shriver & JacobsonJoseph L. Goldstein, M.D.Dr. Kenneth S. and Sharon F. GraffDr. and Mrs. Ira GreenSusan G. GreenCharles B. Hammond, M.D.Jeffrey H. HargettHarley Anderson Haynes, M.D.Howard L. HochmanDr. and Mrs. Jay H. HoofnagleR. Rodney Howell, M.D.Eric and Naomi JakobssonBernard W. Janicki, Ph.D.John Wiley & Sons, Ltd.Elke Jordan, Ph.D.Dr. and Mrs. Allen P. KaplanAbba J. Kastin, M.D.Dr. Thomas J. Kennedy, Jr., TrustDr. Mary J. KennettDr. Charles H. and Janice F. KirkpatrickDr. Mark A. KnepperJohanna L. Kool and Mark KarnsDr. Deloris E. KoziolFrank W. LabarberaR.W. Lamont-Havers, M.D.Dr. Robert J. LevineLeslie S. Libow, M.D.Todd C. MackayGerald C. and Judith G. MacksMacmillan Publishing Ltd.Dr. Edward L. MarutBarbara and Patrick McGareyAmy L. McGuireEXPANDING BOUNDARIES FOR HUMAN HEALTHFOUNDATION FOR THE National Institutes of Health, Inc. 25

The following partners have made theFoundation’s programs possible.FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC.Financial Statements with Supplementary Information and Independent Auditor’s ReportWE ARE GRATEFUL FOR THEIR SUPPORT AND INVOLVEMENTDr. and Mrs. Carl R. MerrilFrank L. and Linda MeyskensJack Albert MillardMillennium Pharmaceuticals, Inc.Dr. and Mrs. Paul M. MontroneNatureDr. Elizabeth F. Neufeld and Mr. Benjamin S. NeufeldArthur W. Nienhuis, M.D.Cindy NordlieEmily B. O’ConnorArthur Oleinick, M.D., JDKristin J. OliverIra H. Pastan, M.D.Betty L. Patterson and Polly Hoeflich in memoryof Primo J. BrunoDr. and Mrs. Steven M. PaulLance R. and Sheila PohlThe Honorable John Edward PorterCharles R. and Susan PucieTibberly G. RichardNoemi B. and Roberto A. RodriguezMr. and Mrs. Bruce W. Rogers, Jr.Dr. and Mrs. Lanny J. RosenwasserJerald S. and Joyce S. SachsMrs. Jillian SacklerMrs. Lily SafraAlan M. Salinger, M.D.Dr. and Mrs. Charles A. SandersWendy R. Sanhai, Ph.D.Stony Brook University Physician AssistantStudent SocietyHoward K. and Ethel L. SchachmanDr. and Mrs. Mark S. SchifferJohn F. ShermanMartha K. ShirkoDr. Ellen V. Sigal and Mr. Gerald R. SigalThe Albert and Lillian Small FoundationSolomon H. Snyder, M.D., and Mrs. Elaine B. SnyderDr. Alan Solomon, M.D.Dr. and Mrs. Stephen P. SpielbergJames R. and Barbara StabenauJuli Staiano and Marc WashingtonSamuel Stehnach, Jr.Dr. and Mrs. Robert S. StoneSunTrust Bank Mid-Atlantic FoundationDrs. Herbert Tabor and Celia White TaborDr. Philip R. Taylor and Ms. Marie A. HolbrookFrederick H. TestSamuel and Paula ThierRobert L. and Barbara S. TrelstadUnited Way of the National Capital AreaDr. and Mrs. Eugene J. Van ScottEric Weinmann in honor ofMrs. William McCormick Blair, Jr.Florence F. WheelerStaci WilliamsDr. and Mrs. Samuel H. WilsonErwin and Jane WolfDrs. Richard and Linda WyattDr. and Mrs. Kenneth YamadaDr. and Mrs. Stuart H. YuspaDr. Anne ZajicekGIFTS IN KINDThe Honorable and Mrs. William McCormick Blair, Jr.Madison Cox Design, Inc.Design CuisineFried, Frank, Harris, Shriver & JacobsonRodale Inc.26 FOUNDATION FOR THE National Institutes of Health, Inc.EXPANDING BOUNDARIES FOR HUMAN HEALTH

FOUNDATIONFOR THE National Institutes of Health, IncDONORSFOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTHFinancial Statements with Supplementary Information and Independent Auditor’s ReportEndowments at the Foundation for NIHThrough endowment gifts, donors ensure perpetual support for a variety of biomedical research andhealth initiatives at the Foundation for NIH. The annual investment income generated by anendowment fund covers program expenses, while the principal remains intact to ensure future funding.John Laws Decker Memorial FundBegun in 2003 through a generous gift from Mrs. Lucille Decker and the Decker family, theJohn Laws Decker Memorial Fund at the Foundation for the National Institutes of Health will establisha permanent lecture at the National Institutes of Health. The endowment and the lectures it supportswill stand as a permanent and fitting tribute to the memory of beloved husband and father,John Laws Decker, M.D.John I. and Elaine K. Gallin EndowmentThe Gallin Endowment will provide amenities at the Edmond J. Safra Family Lodge for familymembers accompanying loved ones participating in clinical trials at the NIH Bethesda, Md. campus.The endowment was established in 1999 in anticipation of the opening of the Safra Family Lodge inearly 2005.GlaxoSmithKline Endowment FundThe GlaxoSmithKline Endowment will support services for families staying at the Edmond J. SafraFamily Lodge, including programs that will help residents stay in touch with employers and loved ones,as well as a variety of other activities.Sallie Rosen Kaplan Fund for Women Scientists in Cancer ResearchThe Kaplan Fund, established in 2000, provides annual support for the Sallie Rosen KaplanFellowships for Women Scientists in Cancer Research. These post-doctoral fellowship awards are givenannually to one or more outstanding woman scientists at the National Cancer Institute.Robert Whitney Newcomb Memorial FundThis permanent fund was established in 2000 by the Newcomb family. Through a charitable remaindertrust, the Newcomb Memorial Fund endows an annual lecture in neuroscience as well as internships forhigh-school students at the National Institute of Neurological Disorders and Stroke. In 2003, theprogram was expanded to include a year-long internship in addition to the summer internship begun in2002, both for promising high-school students with a passion for biomedical research.Norman P. Salzman Memorial FundDr. Norman Salzman’s family, colleagues and friends remember the legacy of this noted pioneer inmolecular biology through contributions to the Salzman Memorial Fund, which supports an annualsymposium and award in virology. The November 2003 Fourth Annual Norman P. SalzmanSymposium in Virology focused on bioterroism and was attended by a record 250 researchers, medicalstudents and health professionals.Harry and Jeanette Weinberg Endowment at the Edmond J. Safra Family LodgeThe Weinberg Endowment was begun in 2002 and will support the operation and maintenance of theEdmond J. Safra Family Lodge—ensuring that guests will be provided a comfortable home away fromhome for years to come.EXPANDING BOUNDARIES FOR HUMAN HEALTHFOUNDATION FOR THE National Institutes of Health, Inc. 27

FOUNDATIONFOR THE National Institutes of Health, IncBOARDFOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTHFinancial Statements with Supplementary Information and Independent Auditor’s ReportBOARD OF DIRECTORSCharles A. Sanders, M.D.ChairmanRetired Chairman & CEOGlaxo, Inc.The Honorable John Edward PorterVice ChairmanHogan & Hartson L.L.P.Mrs. William McCormick Blair, Jr.SecretaryVice President & DirectorAlbert & Mary Lasker FoundationPaul M. Montrone, Ph.D.TreasurerChairman & CEOFisher Scientific International Inc.Paul Berg, Ph.D.Cahill Professor,Emeritus in BiochemistryDirector, Emeritus of the Beckman Center forMolecular and Genetic MedicineStanford University School of MedicineLuther W. Brady, M.D.Distinguished University ProfessorHylda Cohn/American Cancer SocietyProfessor of Clinical Oncology andProfessor, Department of Radiation OncologyDrexel University College of MedicineMrs. William CafritzTrusteeThe John F. Kennedy Center for the Performing ArtsLloyd N. Cutler, EsquireSenior CounselWilmer, Cutler & PickeringMark D. EinChief Executive OfficerVenturehouse Group, LLCJoshua Lederberg, Ph.D.Sackler Foundation ScholarThe Rockefeller UniversityPhilip A. Pizzo, M.D.DeanStanford University School of MedicineJillian SacklerPresident and CEOAMS Foundation for the Arts, Sciences & HumanitiesMrs. Lily SafraChairmanThe Edmond J. Safra Philanthropic FoundationEllen V. Sigal, Ph.D.ChairpersonFriends of Cancer ResearchSolomon H. Snyder, M.D.DirectorDepartment of NeuroscienceJohns Hopkins University School of MedicineAlfred Sommer, M.D., M.H.S.DeanJohns Hopkins Bloomberg School of Public HealthStephen P. Spielberg, M.D., Ph.D.DeanDartmouth Medical SchoolVice President for Health AffairsDartmouth CollegePatrick C. Walsh, M.D.Professor & DirectorJames Buchanan Brady Urological InstituteJohns Hopkins Medical InstitutionsEX OFFICIO NON-VOTINGLester M. Crawford, D.V.M., Ph.D.Acting CommissionerFood and Drug AdministrationElias Zerhouni, M.D.DirectorNational Institutes of HealthSteven M. Paul, M.D.Executive Vice President, Science and TechnologyEli Lilly and CompanyPresidentLilly Research Laboratories28 FOUNDATION FOR THE National Institutes of Health, Inc.EXPANDING BOUNDARIES FOR HUMAN HEALTH

STAFFAmy L. McGuireExecutive DirectorEmily O’ConnorExecutive AssistantPUBLIC-PRIVATE PARTNERSHIPSWendy Sanhai, Ph.D.Director, Public-Private PartnershipsMichael P. Lee, MPHProgram OfficerKen SonnenbergAdministrative AssistantGRAND CHALLENGES IN GLOBAL HEALTHDaniel J. Carucci, M.D., Ph.D.Director, Grand Challenges in Global Health InitiativeTiziano DiPaolo, M.S.Scientific Grants AdministratorElke Jordan, Ph.D.Associate Director, Scientific InitiativesMartin B. SchneidermanProgram ManagerSusan Wiener, M.A.Grants Program AnalystDEVELOPMENTJuli Staiano, CFREDirector, DevelopmentLinda MounadiDevelopment AssistantTibberly G. RíchardCorporate Membership and Communications LiaisonCarla RobinsonManager, Donor RelationsLysander VereenManager, Development RecordsJulie Wolf-RoddaDevelopment Officer, Cancer InitiativesCOMMUNICATIONS AND PUBLIC AFFAIRSCharles R. Pucie, Jr.Senior Advisor, Communications and Public AffairsOPERATIONSGary R. Barbarash, MBPASenior Advisor, Operations and ManagementColleen Clancy, CPAChief Financial OfficerEva CoyneStaff AccountantPeggy J. GerlacherOperations AssociateNoemi B. RodriguezStaff Accountant

1 Cloister Court, Suite 152Bethesda, MD 20814-1460(301) 402-5311www.fnih.org